SynthesisPloS one2018

The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.

Gao Chanchan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.